Baxter International Inc. (BAX) shares gained 0.56% in after-hours on Tuesday, August 31, 2021, and closed the trading at $76.65. Earlier in the normal trading session of Tuesday, BAX’s stock went up 0.29%. The stock volume remained 5.21 million shares, which was higher than the average daily volume of 3.15 million shares within the past 50 days. BAX shares have fallen 12.46% over the last 12 months, and they have moved up 2.27% in the past week. Over the past three months, the stock has lost 6.59%, while over the past six months, it has declined 1.21%.
Lets’s see what’s going on with Baxter?
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our 5 Best Growth Stocks To Own For 2023.
Is BAX acquiring Hill-Rom?
Baxter International Inc (BAX) is in advanced talks to acquire Hill-Rom Holdings Inc. for about $10 billion.
According to the Wallstreet report, a takeover deal could value Hill-Rom at around $150 per share, and the agreement could be reached by midweek if the talks do not fall apart. Earlier, Hill-Rom rejected a $9.6 billion takeover offer from Baxter. Hill-Rom saw Baxter’s proposal of about $144 per share as too low.
Hill-Rom currently has nearly $9 billion market capitalization, while Baxter’s is around $37 billion.
BAX collaboration with UNICEF USA
On August 18, 2021, The Baxter International Foundation, the philanthropic arm of Baxter International Inc (BAX), and UNICEF USA announced a partnership to improve access to safe water in La Guajira, Colombia. A $1.5 million grant from the Foundation is fueling the three-year initiative aimed at ensuring thousands of children, adolescents, families, and communities benefit from basic water, sanitation, and hygiene services.
FDA Class I recall for BAX software
On August 13, 2021, FDA FDA issued a Class I recall, the most serious kind of recall, for Baxter International Inc’s (BAX) Dose IQ safety software used with Spectrum IQ Infusion System.
The Dose IQ safety software allows care providers to create a drug library of pre-programmed dosing information for specific medications delivered into a person’s body in controlled amounts using the Spectrum IQ infusion pump. The recall occurred due to a software defect that may lead to mismatched drug information in drug libraries created using version 9.0.x of the computer-based software.
The recall was announced after 15 recent complaints, but no injuries and no deaths were reported for the issue. In total, Baxter Healthcare recalled 61 devices since initiating the recall on July 7, 2021.
BAX collaboration with AWS
On August 02, 2021, Baxter International Inc (BAX) announced that it is working with Amazon Web Services, Inc (AWS) to enable cloud technology solutions to drive its digital transformation forward.
Baxter extended its multi-year strategic agreement with AWS to further drive the company’s use of the cloud as a foundational element of its technology infrastructure.
The recent speculation about its intention to acquire Hill-Rom is the reason behind its minor gains on Tuesday and it can continue to surge on Wednesday as well.